The value of family history in screening for type 2 diabetes comorbidity
Section snippets
Contributors
There are no other contributors besides the author.
Role of the funding source
There was no funding source for this article.
Declaration of competing interest
There are no conflicts of interest. The author is a full-time employee of Takeda Pharmaceuticals.
Acknowledgements
There are no acknowledgements for this article.
References (18)
- et al.
At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia
Biol. Psychiatry
(2011) - et al.
Accuracy of self-reported family history is strongly influenced by the accuracy of self-reported personal health status of relatives
J. Clin. Epidemiol.
(2012) - et al.
Rethinking the genetic basis for comorbidity of schizophrenia and type 2 diabetes
Schizophr. Res.
(2010) - et al.
Increased cardiometabolic dysfunction in first-degree relatives of patients with psychotic disorders
Schizophr. Res.
(2015) - et al.
Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline
Schizophr. Res.
(2006) - et al.
Polygenic risk for type 2 diabetes mellitus among individuals with psychosis and their relatives
J. Psychiatr. Res.
(2016) - et al.
An overview of diabetes management in schizophrenia patients: office based strategies for primary care practitioners and endocrinologists
Int. J. Endocrinol.
(2015) - et al.
Family history, diabetes, and other demographic and risk factors among participants of the National Health and Nutrition Examination Survey 1999-2002
Prev. Chronic Dis.
(2005) - et al.
Meta-analysis of comorbid diabetes and family history of diabetes in non-affective psychosis
Schizophr. Res.
(2019)
There are more references available in the full text version of this article.
Cited by (0)
© 2020 Elsevier B.V. All rights reserved.